NORMAL SITUATION

Apotheek Willebroek

Export PDF

Company — Normal situation.

Financial year 2024 · Closed on 31/12/2024

Net result84,6 k €-44,6 %over 1 year
Gross margin205 k €-53,3 %over 1 year
Equity397,2 k €+27,0 %over 1 year
Workforce3,4 ETP0,0 %over 1 year

Identity

Source · BCE/KBO

Apotheek Willebroek is a company registered in Belgium. It employs on average 3,4 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0436.298.377
Legal form
Private limited company
Contributed capital
18 600,00 €
Latest accounts
31/12/2024
Average workforce
3,4 ETP
Joint committees (2)
  • 313
  • 3130
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 32 filings

Trend over 19 financial years

20242023202220212020
Income statement
Gross margin205 k €439,1 k €374,4 k €260,5 k €198,6 k €
EBITDA139,9 k €240,4 k €163,6 k €156,3 k €126,8 k €
Operating result121,4 k €213,7 k €134,7 k €127,8 k €105,9 k €
Net result84,6 k €152,7 k €96,1 k €90,1 k €100,3 k €
Balance sheet
Equity397,2 k €312,6 k €159,9 k €159,9 k €132,8 k €
Total assets498 k €622,2 k €565,1 k €553,1 k €515,1 k €
Cash310,9 k €186,8 k €117,5 k €97,6 k €80,8 k €
Debts100,7 k €309,3 k €405 k €385,7 k €382,1 k €
Other
Workforce3,4 ETP3,4 ETP4,2 ETP2,1 ETP1,7 ETP

Board of directors

Source · NBB, accounts to 31/12/2024

1 active · 5 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Geert Reyniers
Managing director15/04/2024 → 13/06/2030

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Apoplus0667.565.282Represented by Carlos Ortega Saez
Directorsince 08/12/2016Managersince 08/12/2016
TM Pharma0881.130.182Represented by Carlos Otega Saez
Director08/12/2016 → 15/04/2024
EUROSAN INTER PRODUCTION0444.432.422Represented by STEFAAN HENDRICKX
Directorsince 01/09/2009

Full financial information

Source · NBB
202420232022202120202019
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202401/01/202301/01/202201/01/202101/01/202001/01/2019
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date23/06/202528/03/202420/07/202315/07/202229/06/202119/06/2020
General meeting12/06/202527/03/202414/06/202308/06/202209/06/202110/06/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 32 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202412/06/202523/06/2025FrenchPDF
Abridged model31/12/202327/03/202428/03/2024DutchPDF
Abridged model31/12/202214/06/202320/07/2023DutchPDF
Abridged model31/12/202108/06/202215/07/2022DutchPDF
Abridged model31/12/202009/06/202129/06/2021DutchPDF
Abridged model31/12/201910/06/202019/06/2020DutchPDF
Abridged model31/12/201812/06/201924/06/2019DutchPDF
Abridged model31/12/201713/06/201819/06/2018DutchPDF
Abridged model31/12/201614/06/201713/07/2017DutchPDF
Abridged model31/12/201508/06/201630/06/2016DutchPDF
Abridged model31/12/201410/06/201506/08/2015DutchPDF
Abridged model31/12/201311/06/201426/08/2014DutchPDF
Abridged model31/12/201212/06/201312/07/2013DutchPDF
Abridged model31/12/201113/06/201221/08/2012DutchPDF
Abridged model31/12/201008/06/201114/07/2011DutchPDF
Abridged model31/12/200909/06/201020/07/2010DutchPDF
Abridged model31/12/200830/06/200923/07/2009DutchPDF
Abridged model31/12/200711/06/200831/07/2008DutchPDF
Abridged model31/12/200613/06/200730/07/2007DutchPDF
Abridged model31/12/200530/06/200617/07/2006DutchPDF
Abridged model31/12/200430/06/200506/07/2005DutchPDF
Abridged model31/12/200330/06/200403/12/2004DutchPDF
Abridged model31/12/200227/05/200330/09/2003DutchPDF
Abridged model31/12/200114/05/200208/07/2002DutchPDF
Abridged model31/12/200003/07/200116/07/2001DutchPDF
Abridged model31/12/199917/07/200016/10/2000DutchPDF
Abridged model31/12/199811/05/199917/09/1999DutchPDF
Abridged model31/12/199719/09/199812/11/1998Dutch—
Abridged model31/12/199613/05/199704/07/1997Dutch—
Abridged model31/12/199514/05/199621/06/1996Dutch—
Abridged model31/12/199406/05/199508/06/1995Dutch—
Abridged model31/12/198908/05/199010/07/1990Dutch—

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

1 active · 5 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Geert Reyniers
Managing director15/04/2024 → 13/06/2030

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Apoplus0667.565.282Represented by Carlos Ortega Saez
Directorsince 08/12/2016Managersince 08/12/2016
TM Pharma0881.130.182Represented by Carlos Otega Saez
Director08/12/2016 → 15/04/2024
EUROSAN INTER PRODUCTION0444.432.422Represented by STEFAAN HENDRICKX
Directorsince 01/09/2009

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Restructuring28/05/2025
    Opération assimilée à la fusion par absorption par la SRL Apoplus-
    PDF
  • Restructuring11/03/2025
    projet de fusion
    PDF
  • Other13/02/2025
    TOEKENNING VAN VOLMACHTEN TOT BANKVERRICHTINGEN
    PDF
  • Registered office04/07/2024
    Verplaatsing van de zetel van de vennootschap naar het Brussel-
    PDF
  • Mandates07/05/2024
    Ontslag en benoeming bestuurders, benoeming commissaris- Benoeming
    PDF
  • Mandates17/10/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - BENAMING - DIVERSEN - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
    PDF
  • Registered office22/03/2018
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates31/01/2017
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Name
Registered office
Annual accounts
Filings19 filings
Mandates
Geert Reyniers
Apoplus
TM Pharma
EUROSAN INTER PRODUCTION
Alice Grobben Verpoorten
Stefaan Hendrickx
1994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027202820292030
Kollni
Dendermondsesteenweg 151, 2830 Willebroek
Managing director
Director
Manager
Manager
Manager
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Square Marie Curie 30, 1070 Anderlecht
accounts 2024
Accounts 2024 · 2025-00170114
Dendermondsesteenweg 151, 2830 Willebroek
accounts 2021 → 2023
Accounts 2023 · 2024-00051249

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
APOTHEEK WILLEBROEK
accounts 2024
Accounts 2024 · 2025-00170114
Kollni
accounts 2021 → 2023
Accounts 2023 · 2024-00051249

Events

  1. 2024
    Annual accounts 202484,6 k €↓
  2. 2024
    Name changeAPOTHEEK WILLEBROEK
  3. 2023
    Annual accounts 2023152,7 k €↑
  4. 2022
    Annual accounts 202296,1 k €↑
  5. 2021
    Annual accounts 202190,1 k €↓
  6. 2020
    Annual accounts 2020100,3 k €↑
  7. 2019
    Annual accounts 201927,3 k €↑
  8. 2018
    Annual accounts 2018-61,3 k €↓
  9. 2017
    Annual accounts 2017-1 k €↓
  10. 2016
    Annual accounts 201626,6 k €↑
  11. 2015
    Annual accounts 201523,2 k €↓
  12. 2014
    Annual accounts 201423,9 k €↑
  13. 2013
    Annual accounts 20137,4 k €↓
  14. 2012
    Annual accounts 201219,4 k €↑
  15. 2011
    Annual accounts 201111,7 k €↓
  16. 2010
    Annual accounts 201018,9 k €↓
  17. 2009
    Annual accounts 200926,1 k €↑
  18. 2008
    Annual accounts 200822,7 k €↑
  19. 2007
    Annual accounts 200720,7 k €↑
  20. 2006
    Annual accounts 20062,9 k €